ClinicalTrials.gov
History of Changes for Study: NCT04328844
A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers
Latest version (submitted May 13, 2022) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 March 30, 2020 None (earliest Version on record)
2 April 1, 2020 Outcome Measures and Study Status
3 August 24, 2021 Contacts/Locations, Conditions, Study Status, Eligibility, Outcome Measures and Study Design
4 May 13, 2022 Arms and Interventions, Study Status, Study Design, Conditions, Eligibility and Study Description
Comparison Format:
U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services